NCCN VERSION 2 2015

NCCN Guidelines Version 2.2015 Breast Cancer

NCCN Guidelines Index Breast Cancer Table of Contents Discussion

2006;98:599-609. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16670385 .

2001;67:513-519. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11409797 .

130. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer--a multicenter validation study. N Engl J Med 1998;339:941-946. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9753708 . 131. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11:927-933. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20863759 . 132. Kuehn T, Vogl FD, Helms G, et al. Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi- institutional trial. Eur J Surg Oncol 2004;30:252-259. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15028305 . 133. McMasters KM, Giuliano AE, Ross MI, et al. Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med 1998;339:990-995. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9753717 . 134. O'Hea BJ, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-427. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9544956 . 135. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-553. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12904519 . 136. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst

137. Cox CE, Salud CJ, Cantor A, et al. Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg 2001;193:593-600. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11768674 . 138. Dupont E, Cox C, Shivers S, et al. Learning curves and breast cancer lymphatic mapping: institutional volume index. J Surg Res 2001;97:92-96. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11319887 . 139. Giuliano AE, Hawes D, Ballman KV, et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA 2011;306:385-393. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21791687 . 140. Degnim AC, Reynolds C, Pantvaidya G, et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 2005;190:543-550. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16164917 . 141. Houvenaeghel G, Nos C, Giard S, et al. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol 2009;35:690- 695. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19046847 . 142. Katz A, Smith BL, Golshan M, et al. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol 2008;26:2093-2098. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18445838 . 143. Kohrt HE, Olshen RA, Bermas HR, et al. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 2008;8:66-66. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18315887 .

Version 2.2015, 03/11/15 © National Comprehensive Cancer Network, Inc. 2015, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®. MS-76